Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review

Tomohito Tanaka, Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Sousuke Hashida(Osaka University of Pharmaceutical Sciences), Kohei Taniguchi(Osaka University of Pharmaceutical Sciences), Shinichi Terada(Osaka Medical and Pharmaceutical University), Shunsuke Miyamoto(Osaka Medical and Pharmaceutical University), Ruri Nishie(Osaka Medical and Pharmaceutical University), Satoshi Tsunetoh(Osaka Medical and Pharmaceutical University), Hiromi Konishi(Osaka Medical and Pharmaceutical University), Kazumasa Komura(Kawasaki Medical School), Shoko Ueda(Osaka Medical and Pharmaceutical University), Hiroshi Sasaki(Osaka Medical and Pharmaceutical University), Yuhei Kogata(Osaka University of Pharmaceutical Sciences)
Journal of Clinical Medicine
May 6, 2022
10.3390/jcm11092606
Cited by 12

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line
|Journal of Biological Chemistry|1999|174